Blood cancer Patients' vaccine response under the microscope

NCT ID NCT05170399

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 6 times

Summary

This study looks at how well vaccines for flu, COVID-19, shingles, hepatitis B, and pneumonia work in people with certain blood cancers like chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas. Researchers will measure immune responses through blood samples before and after vaccination. Up to 500 adults will participate, and some may pause their cancer treatment temporarily to see if that improves vaccine effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
vaccines (influenza, shingles, pneumococcal, hepatitis B, COVID-19)
What this could lead to
If successful, this could help doctors recommend better vaccine schedules for people with blood cancers, potentially improving protection against preventable diseases.
What could go wrong
This is an observational study, not testing a new treatment. Results may not apply to all blood cancer patients, and vaccine responses may still be weak in some individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.